658 related articles for article (PubMed ID: 17438147)
1. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
[TBL] [Abstract][Full Text] [Related]
2. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
Joner M; Finn AV; Farb A; Mont EK; Kolodgie FD; Ladich E; Kutys R; Skorija K; Gold HK; Virmani R
J Am Coll Cardiol; 2006 Jul; 48(1):193-202. PubMed ID: 16814667
[TBL] [Abstract][Full Text] [Related]
3. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
7. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.
Artang R; Dieter RS
Am J Cardiol; 2007 Apr; 99(8):1039-43. PubMed ID: 17437724
[TBL] [Abstract][Full Text] [Related]
9. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
11. Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV; Nakazawa G; Virmani R
Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
[TBL] [Abstract][Full Text] [Related]
12. Very late bare-metal stent thrombosis. A case report and review of the literature.
Manjappa N; Agarwal A; Cavusoglu E
J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents and stent thrombosis: a cause for concern?
Wernick MH; Jeremias A; Carrozza JP
Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
[TBL] [Abstract][Full Text] [Related]
14. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
[TBL] [Abstract][Full Text] [Related]
15. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
16. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
17. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
[TBL] [Abstract][Full Text] [Related]
19. Very late thrombosis after drug-eluting stents.
Feres F; Costa JR; Abizaid A
Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis.
Filion KB; Roy AM; Baboushkin T; Rinfret S; Eisenberg MJ
Am J Cardiol; 2009 Feb; 103(3):338-44. PubMed ID: 19166686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
